Trials / Active Not Recruiting
Active Not RecruitingNCT06971185
A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept
Treatment Patterns and Effectiveness of Luspatercept in the Real World
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 430 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to understand the treatment patterns and clinical outcomes of myelodysplastic syndromes patients treated with luspatercept or erythropoiesis-stimulating agents
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Luspatercept | As per product label |
| DRUG | Erythropoiesis-stimulating agent (ESA) | As per product label |
Timeline
- Start date
- 2024-11-22
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
- First posted
- 2025-05-14
- Last updated
- 2025-05-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06971185. Inclusion in this directory is not an endorsement.